{"text": ["Eli", "Lilly-Vir", "Bamlanivimab-VIR-7831", "Combo", "Reduces", "Viral", "Load", "By", "70%", "In", "Low-Risk", "COVID-19", "Patients"], "created_at": "2021-03-29 13:32:52"}
{"text": ["UPDATE", "1-Lilly-Vir's", "COVID-19", "antibody", "combo", "reduces", "viral", "load", "in", "study"], "created_at": "2021-03-29 13:05:44"}
{"text": ["Eli", "Lilly,", "Vir", "and", "Glaxo", "say", "Phase", "2", "trial", "combining", "antibodies", "reduced", "viral", "load", "by", "70%", "at", "day", "7"], "created_at": "2021-03-29 12:44:00"}
{"text": ["Lilly,", "Vir", "Biotechnology", "and", "GSK", "Announce", "Positive", "Topline", "Data", "from", "the", "Phase", "2", "BLAZE-4", "Trial", "Evaluating", "Bamlanivimab", "with", "VIR-7831", "in", "Low-Risk", "Adults", "with", "COVID-19"], "created_at": "2021-03-29 12:30:00"}
{"text": ["This", "Stalwart's", "Growth", "Story", "Isn't", "Over", "Yet"], "created_at": "2021-03-29 11:12:00"}
